RhoVac is a pharmaceutical company. Today, the focus is on the development of vaccines for the treatment of metastatic cancer. Immunotherapy treatment is a significant part of the operations where the body's immune system is used to fight and eliminate cancer cell. The company's drug candidate is used in combination with surgery or radiation therapy. The company was established in 2007 and is based in Lund.

Kurser for RhoVac AB

Lige nu

+/-
-0,02
%
-0,19%
Seneste
10,66
Højeste
10,68
Laveste
10,02
Volumen
13 731
Omsætning (SEK)
142 287
Værdi (MSEK)
203,0

Bestyrelse og direktion

Adm. direktør

  • Anders Månsson

Bestyrelsesformand

  • Gunnar Gårdemyr

Bestyrelse

  • Anders Ljungqvist
  • Cristina Glad
  • Gunnar Gårdemyr
  • Lars Hedbys

Film

Kommende rapporter

  • 2020-05-05 Delårsrapport 2020-Q1

  • 2020-05-12 Årsstämma 2019

  • 2020-08-28 Delårsrapport 2020-Q2

  • 2020-11-13 Delårsrapport 2020-Q3